VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Herbst on the 2011 Lung Cancer Congress Topics

Roy S. Herbst, MD, PhD
Published: Monday, Aug 08, 2011

Roy S. Herbst, MD, PhD, Chief of Medical Oncology, Yale Comprehensive Cancer Center, and co-chair of the 12th International Lung Cancer Congress, discusses the screening topics that will be discussed at the Congress taking place at the Park Hyatt Aviara in Carlsbad, CA, August 11-14, 2011.

Herbst explains that there are still as many questions as there are answers. He believes the next step for the oncology academic community is to use molecular epidemiology to identify patients at the most risk and to discover minimally invasive techniques and treatment options for early lesions to prevent metastatic cancer.
Roy S. Herbst, MD, PhD, Chief of Medical Oncology, Yale Comprehensive Cancer Center, and co-chair of the 12th International Lung Cancer Congress, discusses the screening topics that will be discussed at the Congress taking place at the Park Hyatt Aviara in Carlsbad, CA, August 11-14, 2011.

Herbst explains that there are still as many questions as there are answers. He believes the next step for the oncology academic community is to use molecular epidemiology to identify patients at the most risk and to discover minimally invasive techniques and treatment options for early lesions to prevent metastatic cancer.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine TumorsMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x